Skip to main content
. 2015 Oct 6;55(8):2389–2397. doi: 10.1007/s00394-015-1045-4

Fig. 1.

Fig. 1

Disposition of subjects for placebo (maltodextrin) and digestion-resistant maltodextrin (RMD) groups